Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Sexually Transmitted Diseases

Free Subscription Articles published in J Natl Cancer Inst Retrieve available abstracts of 28 articles: HTML format

Single Articles

January 2026
1. DE POKOMANDY A
   Could clearance of HPV open the door to HIV?
   J Natl Cancer Inst. 2026 Jan 28:djaf380. doi: 10.1093.
   PubMed    
   
   
   
2. DAS D, Hirayama S, Aye L, Bryan ME, et al
   Circulating tumor human papillomavirus DNA whole genome sequencing enables human papillomavirus-associated oropharynx cancer early detection.
   J Natl Cancer Inst. 2026;118:58-67.
   PubMed     Abstract available
   
   
   November 2025
3. HATHAWAY CL, Brown ER, Cherne S, Sepulveda AL, et al
   Association of HPV on risk of HIV acquisition in african women: Analyses from MTN-020/ASPIRE.
   J Natl Cancer Inst. 2025 Nov 19:djaf336. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. ROUTMAN DM, Hidalgo AM, Chaudhuri AA
   Liquid biopsy for very early detection of HPV-associated oropharyngeal cancer.
   J Natl Cancer Inst. 2025 Nov 11:djaf302. doi: 10.1093.
   PubMed    
   
   
   October 2025
5. ZHAO R, Kulasingam S, Alarid-Escudero F, Minihan AK, et al
   Public-health impact of increasing human papillomavirus vaccination and cervical cancer screening.
   J Natl Cancer Inst. 2025 Oct 24:djaf311. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. BEFANO B, Kalpathy-Cramer J, Egemen D, Inturrisi F, et al
   Initial evaluation of a new cervical screening strategy combining human papillomavirus genotyping and automated visual evaluation: the Human Papillomavirus-Automated Visual Evaluation Consortium.
   J Natl Cancer Inst. 2025;117:2124-2129.
   PubMed     Abstract available
   
   
   July 2025
7. SANNIGRAHI MK, Raghav L, Rich DJ, Schrank TP, et al
   Tumor-intrinsic and immune-related features associated with treatment failure in human papillomavirus-related oropharyngeal cancer.
   J Natl Cancer Inst. 2025;117:1366-1376.
   PubMed     Abstract available
   
   
   
8. KAVA CM, Chaturvedi AK, Senkomago V, Mix JM, et al
   The role of human papillomavirus 16 in oral cavity and laryngeal cancers in the United States.
   J Natl Cancer Inst. 2025;117:1492-1497.
   PubMed     Abstract available
   
   
   June 2025
9. HOLMQVIST AS, Meng Q, Landier W, Hageman L, et al
   Human papillomavirus-related squamous cell carcinomas after blood or marrow transplantation-a Blood or Marrow Transplant Survivor Study report.
   J Natl Cancer Inst. 2025;117:1166-1174.
   PubMed     Abstract available
   
   
   May 2025
10. VAN DEN BORST E, Bell M, Op De Beeck K, Van Camp G, et al
    Lineages and sublineages of high-risk HPV types associated with cervical cancer and precancer: a systematic review and meta-analysis.
    J Natl Cancer Inst. 2025 May 16:djaf118. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. SHING JZ, Giuliano AR, Brenner N, Michels B, et al
    Natural history of HPV-16 E6 serology among cancer-free men in a multicenter longitudinal cohort study.
    J Natl Cancer Inst. 2025;117:915-923.
    PubMed     Abstract available
    
    
    April 2025
12. TSEGAYE AT, Shing JZ, Vo JB, Kreimer AR, et al
    Racial and ethnic differences in HPV-related cancer incidence in the United States, 2001-2020.
    J Natl Cancer Inst. 2025 Apr 26:djaf107. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2025
13. ADCOCK R, Wheeler CM, Hunt WC, Torrez-Martinez NE, et al
    HPV vaccine impact: genotype-specific changes in cervical pre-cancer share similarities with changes in cervical screening cytology.
    J Natl Cancer Inst. 2025 Mar 11:djaf055. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2025
14. LANDY R, Haber GW, Graubard BI, Fakhry C, et al
    Impact of screening for HPV-positive oropharyngeal cancers: a microsimulation-based modeling study.
    J Natl Cancer Inst. 2025 Feb 6:djaf033. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2024
15. PATEL MR, Burtness B, Ferris RL, Saba NF, et al
    The widespread application of trans-oral robotic surgery in HPV-related head and neck cancer: one size does not fit all.
    J Natl Cancer Inst. 2024 Dec 19:djae291. doi: 10.1093.
    PubMed    
    
    
    
16. WHEELER CM, Adcock R, Hunt WC, Robertson M, et al
    HPV genotype-specific prevalence and infection risks: A 10-year population-based study from the United States.
    J Natl Cancer Inst. 2024 Dec 10:djae327. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2024
17. RAMIREZ AT, Mesher D, Baena A, Salgado Y, et al
    Impact of knowledge of HPV positivity on cervical cytology performance in latin america.
    J Natl Cancer Inst. 2024 Nov 12:djae283. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2024
18. TRAKIMAS DR, Mydlarz WK, Mady LJ, Gourin CG, et al
    Lower survival for surgical treatment of HPV-related oropharynx cancer at community cancer centers.
    J Natl Cancer Inst. 2024 Sep 9:djae220. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. DAS S, Wentzensen N, Sawaya GF, Egemen D, et al
    Primary human papillomavirus testing vs cotesting: clinical outcomes in populations with different disease prevalence.
    J Natl Cancer Inst. 2024;116:1525-1529.
    PubMed     Abstract available
    
    
    July 2024
20. TRAKIMAS DR, Mydlarz W, Mady LJ, Koch W, et al
    Increasing radiation therapy and lower survival for human papillomavirus-related oropharynx cancer associated with a shift to community cancer center care.
    J Natl Cancer Inst. 2024;116:1051-1062.
    PubMed     Abstract available
    
    
    March 2024
21. ARBYN M, Rousta P, Bruni L, Schollin Ask L, et al
    Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer.
    J Natl Cancer Inst. 2024 Mar 19:djae042. doi: 10.1093.
    PubMed    
    
    
    
22. GOPALANI SV, Saraiya M, Huang B, Tucker TC, et al
    Population-level incidence of HPV-positive oropharyngeal, cervical, and anal cancers by smoking status.
    J Natl Cancer Inst. 2024 Mar 1:djae054. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
23. GOPALANI SV, Senkomago V, Rim SH, Saraiya M, et al
    Human papillomavirus-associated anal squamous cell carcinoma: sociodemographic, geographic, and county-level economic trends in incidence rates-United States, 2001-2019.
    J Natl Cancer Inst. 2024;116:275-282.
    PubMed     Abstract available
    
    
    January 2024
24. PALMER TJ, Kavanagh K, Cuschieri K, Cameron R, et al
    Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation.
    J Natl Cancer Inst. 2024 Jan 22:djad263. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2023
25. BAANDRUP L, Maltesen T, Dehlendorff C, Kjaer SK, et al
    HPV vaccination and anal high-grade precancerous lesions and cancer: a real-world effectiveness study.
    J Natl Cancer Inst. 2023 Sep 18:djad189. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2023
26. GRADISSIMO A, Clarke MA, Xue X, Castle PE, et al
    A Novel HPV/Host DNA Methylation-Score and Detection of Cervical Adenocarcinoma.
    J Natl Cancer Inst. 2023 Jul 19:djad134. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. BEFANO B, Campos NG, Egemen D, Herrero R, et al
    Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial.
    J Natl Cancer Inst. 2023;115:788-795.
    PubMed     Abstract available
    
    
    April 2023
28. CASTLE PE
    Prophylactic human papillomavirus vaccination for prevention of oropharyngeal cancer in older men: is the juice worth the squeeze?
    J Natl Cancer Inst. 2023;115:349-351.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum